Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML)
Categories (click each to see list of all clinical trials associated with that category): Leukemia/MDS/MPD (ONC)
Current Status: Open
Phase: II
Principal Investigator: Gundabolu, Krishna
Contact Information:
Hillary Stevenson
+1 402-836-9305
hillary.stevenson@unmc.edu
Eligibility: https://www.clinicaltrials.gov/ct2/show/NCT03836209?cond=NCT03836209&draw=2&rank=1#eligibility
Summary